I’ve reported previously (18 times) on Israeli biotech Pluristem’s PLX stem cell treatment for many life-threatening conditions. Recent lab trials with modified PLX cells showed significant inhibitory effect on various lines of breast, colorectal, kidney, liver, lung, muscle and skin cancers.
http://www.pluristem.com/wp-content/uploads/2018/01/PLX_Cancer_Publication_final_isa.pdf